- Home
- NBIX vs SWK Comparison
NBIX vs SWK Comparison
Compare NBIX & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- SWK
- Stock Information
- Founded
- NBIX 1992
- SWK 1843
- Country
- NBIX United States
- SWK United States
- Employees
- NBIX N/A
- SWK N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- SWK Industrial Machinery/Components
- Sector
- NBIX Health Care
- SWK Consumer Discretionary
- Exchange
- NBIX Nasdaq
- SWK Nasdaq
- Market Cap
- NBIX 12.2B
- SWK 11.1B
- IPO Year
- NBIX 1996
- SWK N/A
- Fundamental
- Price
- NBIX $126.55
- SWK $64.55
- Analyst Decision
- NBIX Strong Buy
- SWK Buy
- Analyst Count
- NBIX 20
- SWK 9
- Target Price
- NBIX $163.20
- SWK $90.33
- AVG Volume (30 Days)
- NBIX 915.2K
- SWK 2.6M
- Earning Date
- NBIX 07-31-2025
- SWK 07-29-2025
- Dividend Yield
- NBIX N/A
- SWK 5.08%
- EPS Growth
- NBIX N/A
- SWK N/A
- EPS
- NBIX 2.96
- SWK 2.41
- Revenue
- NBIX $2,412,600,000.00
- SWK $15,240,800,000.00
- Revenue This Year
- NBIX $16.29
- SWK $2.68
- Revenue Next Year
- NBIX $15.08
- SWK $4.46
- P/E Ratio
- NBIX $42.49
- SWK $26.77
- Revenue Growth
- NBIX 21.73
- SWK N/A
- 52 Week Low
- NBIX $84.23
- SWK $53.91
- 52 Week High
- NBIX $157.98
- SWK $110.88
- Technical
- Relative Strength Index (RSI)
- NBIX 64.01
- SWK 45.14
- Support Level
- NBIX $122.66
- SWK $63.84
- Resistance Level
- NBIX $126.00
- SWK $70.00
- Average True Range (ATR)
- NBIX 2.55
- SWK 1.86
- MACD
- NBIX -0.33
- SWK -0.29
- Stochastic Oscillator
- NBIX 72.06
- SWK 28.38
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.